the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Stakeholder Opinions: Heart Failure - When drugs do not work

Published by Datamonitor Contact us : +1-860-674-8796
Published 2008/04 Content info  
Product code DC69065
Price From  US $ 3800 Order/Price list
US $ 3800 PDF by E-mail (Single User License)
US $ 9500 PDF by E-mail (Global License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Abstract

Overview

Introduction

Advanced heart failure is a growing issue. Existing pharmacological strategies increase the survival rates of acute heart failure patients, providing a growing source of patients with advanced disease. In view of long waiting lists for heart transplantation and the growing lack of donors, cardiac resynchronization and mechanical circulatory support devices have demonstrated promising results.

Scope

  • What are the current definitions, diagnostic methods and treatment approaches of the early stages of the disease?
  • What are the main issues surrounding treatment approaches in the advanced stages of the disease?
  • What is the current role of cardiac resynchronization therapy in treatment of advanced heart failure?
  • What are the main non-pharmacological options as alternatives to heart transplantation in advanced heart failure?

Report Highlights

With no new drug therapies addressing advanced heart failure and existing pharmacological strategies failing to compensate a weakening heart, alternative, non-pharmacological solutions have to be found. In view of long waiting lists for heart transplantation and the growing shortage of donor hearts, the focus of treatment must shift onto devices.

Ventricular dyssynchrony is a well recognized problem in advanced stages of heart failure. Clinical trials investigating ventricular dyssynchrony cardiac resynchronization have demonstrated promising results. However, this technology provides only temporary, symptomatic relief and neither cures nor fully stops the progression of the disease.

In light of the growing shortage of donor hearts and failing pharmacological strategies, an artificial mechanical heart has been a long sought-after technology. Although the developments started decades ago, a fully implantable total artificial heart is still at the concept stage, with many years of research and development yet to come.

Reasons to Purchase

  • Understand current definitions, diagnostic methods and treatment approaches in advanced heart failure
  • Current dynamics and future trends of the technology developments treating advanced heart failure
  • Major technological and industry issues surrounding technological progress and new product development
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.